Defining the impact of prognostic factors at the time of relapse for nonmetastatic rhabdomyosarcoma-Reference-Cited by-同舟云学术

Defining the impact of prognostic factors at the time of relapse for nonmetastatic rhabdomyosarcoma

Published:2020-08-29 Issue:12 Volume:67 Page:
ISSN:1545-5009
Container-title:Pediatric Blood & Cancer
language:en
Short-container-title:Pediatr Blood Cancer

Author:

Affinita Maria Carmen¹^ORCID,Ferrari Andrea²^ORCID,Chiaravalli Stefano²,Melchionda Fraia³,Quaglietta Lucia⁴,Casanova Michela²,Zanetti Ilaria¹,Scarzello Giovanni¹,Di Pasquale Luisa⁵,Di Cataldo Andrea⁵^ORCID,Bisogno Gianni¹^ORCID

Affiliation:

1. Oncohematology Division Department of Women's and Children's Health Padova University Hospital Padua Italy

2. Pediatric Oncology Unit Fondazione IRCCS Istituto Nazionale Tumori Milan Italy

3. ‘Lalla Seragnoli’ Pediatric Oncology and Hematology Unit S Orsola‐Malpighi Hospital Bologna Italy

4. Department of Pediatric Oncology Ospedale Santobono‐Pausilipon Naples Italy

5. Pediatric Oncohematology Unit Department of Clinical and Experimental Medicine University of Catania Catania Italy

Publisher

Wiley

Subject

Oncology,Hematology,Pediatrics, Perinatology, and Child Health

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/pbc.28674

Reference10 articles.

1. Rhabdomyosarcoma

2. Prognostic Factors After Relapse in Nonmetastatic Rhabdomyosarcoma: A Nomogram to Better Define Patients Who Can Be Salvaged With Further Therapy

3. Outcomes and prognostic factors after recurrence in children and adolescents with nonmetastatic rhabdomyosarcoma

4. Survival After Relapse in Children and Adolescents With Rhabdomyosarcoma: A Report From the Intergroup Rhabdomyosarcoma Study Group

5. Risk‐based treatment for patients with first relapse or progression of rhabdomyosarcoma: a report from the Children's Oncology Group;Mascarenhas L;Cancer,2009

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A systematic review of combined surgery and brachytherapy approaches for children and young people with relapsed and refractory rhabdomyosarcoma (Local‐REFoRMS);Pediatric Blood & Cancer;2024-04-02

2. Oral vinorelbine and continuous low doses of cyclophosphamide in pediatric rhabdomyosarcoma: a real-world study;Frontiers in Pharmacology;2023-05-03

3. Biological Role and Clinical Implications of MYOD1L122R Mutation in Rhabdomyosarcoma;Cancers;2023-03-07

4. Developments in the Surgical Approach to Staging and Resection of Rhabdomyosarcoma;Cancers;2023-01-10

5. Relapse after non‐metastatic rhabdomyosarcoma: The impact of routine surveillance imaging on early detection and post‐relapse survival;Pediatric Blood & Cancer;2022-11-21